0001181431-11-026370.txt : 20110502 0001181431-11-026370.hdr.sgml : 20110502 20110502173310 ACCESSION NUMBER: 0001181431-11-026370 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110428 FILED AS OF DATE: 20110502 DATE AS OF CHANGE: 20110502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HA NGOC TUAN CENTRAL INDEX KEY: 0001241221 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34655 FILM NUMBER: 11802146 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVEO PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001325879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 SIDNEY STREET STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172995000 MAIL ADDRESS: STREET 1: 75 SIDNEY STREET STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 rrd309869.xml HA-NGOC FORM 4 X0303 4 2011-04-28 0 0001325879 AVEO PHARMACEUTICALS INC AVEO 0001241221 HA NGOC TUAN C/O AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET CAMBRIDGE MA 02139 1 1 0 0 Chief Executive Officer Common Stock 2011-04-28 4 M 0 3300 2.00 A 87704 D Common Stock 2011-04-28 4 S 0 3300 16.0385 D 84404 D Common Stock 170329 I Held by GRAT Stock Option (right-to-buy) 2.00 2011-04-28 4 M 0 3300 0 D 2016-02-09 Common Stock 3300 84200 D The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2011. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.00 to $16.11, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. Shares are held by Gabriel Schmergel, Trustee, or his successor in trust, of the Tuan Ha-Ngoc 2009 GRAT. Mr. Schmergel is trustee of the Tuan Ha-Ngoc 2009 GRAT and he exercises sole voting and investment power over the shares held of record by such trust. Mr. Ha-Ngoc disclaims beneficial ownership over all such shares, except to the extent of his pecurniary interest therein. This option was fully vested as of January 1, 2010. /s/ Joseph D. Vittiglio, attorney-in-fact 2011-05-02